Xuerong Biological announcement, the company plans to set up a wholly-owned subsidiary Shanghai Xuerong Biopharmaceutical Co., Ltd. in Shanghai with its own capital of 30 million yuan. Xuerong Medicine will focus on the commercialization of edible fungus extracts with the functions of promoting white blood cells and activating immune cells, enhancing immunity, antioxidation, antivirus, etc., with emphasis on β-1Rong 3 glucan, β-nicotinamide mononucleotide (NMN) and other products. First of all, cut into functional food, health food, simultaneous development of edible fungus extract in anti-tumor, enhance immunity and other aspects of new drug research and development.
The chairman of the company is Yang Yongping. Mr. Yang Yongping: born in April 1969, Chinese nationality, no permanent residence abroad, college degree, has worked in the Waterway Department of Fujian Port and Navigation Administration, and has served as general manager and chairman of Gaorong Food. The current chairman of the company, vice president of China Edible Fungi Association, Vice President of China Agricultural industrialization leading Enterprises Association, Chairman of Factory Professional Committee of China Edible Fungi Association, Honorary Chairman of Shanghai vegetable Edible Fungi Industry Association, standing Committee member of Shanghai Federation of Industry and Commerce, Honorary Chairman of Shanghai Fujian Chamber of Commerce.
This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.